Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Pancreatitis

  Free Subscription


Articles published in Gut

Retrieve available abstracts of 65 articles:
HTML format



Single Articles


    November 2021
  1. NAYAR M, Varghese C, Kanwar A, Siriwardena AK, et al
    SARS-CoV-2 infection is associated with an increased risk of idiopathic acute pancreatitis but not pancreatic exocrine insufficiency or diabetes: long-term results of the COVIDPAN study.
    Gut. 2021 Nov 11. pii: gutjnl-2021-326218. doi: 10.1136/gutjnl-2021-326218.
    PubMed    


  2. BENITZ S, Crawford H
    Discovery of the pancreatic basal cell: a new candidate for an adult stem cell emerges.
    Gut. 2021 Nov 3. pii: gutjnl-2021-325694. doi: 10.1136/gutjnl-2021-325694.
    PubMed    


    October 2021
  3. LEE B, Namkoong H, Yang Y, Huang H, et al
    Single-cell sequencing unveils distinct immune microenvironments with CCR6-CCL20 crosstalk in human chronic pancreatitis.
    Gut. 2021 Oct 26. pii: gutjnl-2021-324546. doi: 10.1136/gutjnl-2021-324546.
    PubMed     Abstract available


  4. CABASAG CJ, Ferlay J, Laversanne M, Vignat J, et al
    Pancreatic cancer: an increasing global public health concern.
    Gut. 2021 Oct 22. pii: gutjnl-2021-326311. doi: 10.1136/gutjnl-2021-326311.
    PubMed    


  5. OLESEN SS, Phillips AE, Faghih M, Kuhlmann L, et al
    Overlap and cumulative effects of pancreatic duct obstruction, abnormal pain processing and psychological distress on patient-reported outcomes in chronic pancreatitis.
    Gut. 2021 Oct 21. pii: gutjnl-2021-325855. doi: 10.1136/gutjnl-2021-325855.
    PubMed     Abstract available


  6. YANG F, Huang Y, Li T, Fu Y, et al
    Prevalence and outcomes of acute pancreatitis in COVID-19: a meta-analysis.
    Gut. 2021 Oct 20. pii: gutjnl-2021-325941. doi: 10.1136/gutjnl-2021-325941.
    PubMed    


  7. KRYKLYVA V, Luchini C, Stommel MWJ, Nagtegaal ID, et al
    Detecting Lynch syndrome in pancreatic ductal adenocarcinoma FNA cytology based on cancer history and immunocytochemistry.
    Gut. 2021 Oct 19. pii: gutjnl-2021-326033. doi: 10.1136/gutjnl-2021-326033.
    PubMed    


    July 2021
  8. MARTENS S, Coolens K, Van Bulck M, Arsenijevic T, et al
    Discovery and 3D imaging of a novel DeltaNp63-expressing basal cell type in human pancreatic ducts with implications in disease.
    Gut. 2021 Jul 30. pii: gutjnl-2020-322874. doi: 10.1136/gutjnl-2020-322874.
    PubMed     Abstract available


  9. HALLENSLEBEN ND, Timmerhuis HC, Hollemans RA, Pocornie S, et al
    Optimal timing of cholecystectomy after necrotising biliary pancreatitis.
    Gut. 2021 Jul 16. pii: gutjnl-2021-324239. doi: 10.1136/gutjnl-2021-324239.
    PubMed     Abstract available


    June 2021
  10. POTJER TP
    Pancreatic cancer surveillance and its ongoing challenges: is it time to refine our eligibility criteria?
    Gut. 2021 Jun 18. pii: gutjnl-2021-324739. doi: 10.1136/gutjnl-2021-324739.
    PubMed    


  11. LV XH, Deng K, Yang JL
    Duality of the association between COVID-19 and acute pancreatitis.
    Gut. 2021 Jun 15. pii: gutjnl-2021-325221. doi: 10.1136/gutjnl-2021-325221.
    PubMed    


    May 2021
  12. KOSCHNY R, Lang M, Hackert T
    Enormously dilated pancreatic duct.
    Gut. 2021 May 7. pii: gutjnl-2021-324335. doi: 10.1136/gutjnl-2021-324335.
    PubMed    


  13. GENIN E, Cooper DN, Masson E, Ferec C, et al
    NGS mismapping confounds the clinical interpretation of the PRSS1 p.Ala16Val (c.47C>T) variant in chronic pancreatitis.
    Gut. 2021 May 7. pii: gutjnl-2021-324943. doi: 10.1136/gutjnl-2021-324943.
    PubMed    


    April 2021
  14. CHANDRA V, McAllister F
    Therapeutic potential of microbial modulation in pancreatic cancer.
    Gut. 2021 Apr 27. pii: gutjnl-2019-319807. doi: 10.1136/gutjnl-2019-319807.
    PubMed    


  15. HACKENG WM, Brosens LAA, Kim JY, O'Sullivan R, et al
    Non-functional pancreatic neuroendocrine tumours: ATRX/DAXX and alternative lengthening of telomeres (ALT) are prognostically independent from ARX/PDX1 expression and tumour size.
    Gut. 2021 Apr 13. pii: gutjnl-2020-322595. doi: 10.1136/gutjnl-2020-322595.
    PubMed     Abstract available


  16. KLOESCH B, Ionasz V, Paliwal S, Hruschka N, et al
    A GATA6-centred gene regulatory network involving HNFs and DeltaNp63 controls plasticity and immune escape in pancreatic cancer.
    Gut. 2021 Apr 12. pii: gutjnl-2020-321397. doi: 10.1136/gutjnl-2020-321397.
    PubMed     Abstract available


  17. XIE Z, Gao Y, Ho C, Li L, et al
    Exosome-delivered CD44v6/C1QBP complex drives pancreatic cancer liver metastasis by promoting fibrotic liver microenvironment.
    Gut. 2021 Apr 7. pii: gutjnl-2020-323014. doi: 10.1136/gutjnl-2020-323014.
    PubMed     Abstract available


  18. OVERBEEK KA, Levink IJM, Koopmann BDM, Harinck F, et al
    Long-term yield of pancreatic cancer surveillance in high-risk individuals.
    Gut. 2021 Apr 5. pii: gutjnl-2020-323611. doi: 10.1136/gutjnl-2020-323611.
    PubMed     Abstract available


    March 2021
  19. GLEESON FC, Jeraldo P, Levy MJ, Murphy SJ, et al
    Composition, diversity and potential utility of intervention-naive pancreatic cancer intratumoral microbiome signature profiling via endoscopic ultrasound.
    Gut. 2021 Mar 22. pii: gutjnl-2021-324031. doi: 10.1136/gutjnl-2021-324031.
    PubMed    


  20. ZHOU T, Liu J, Xie Y, Yuan S, et al
    ESE3/EHF, a promising target of rosiglitazone, suppresses pancreatic cancer stemness by downregulating CXCR4.
    Gut. 2021 Mar 5. pii: gutjnl-2020-321952. doi: 10.1136/gutjnl-2020-321952.
    PubMed     Abstract available


  21. KOLODKIN-GAL D, Roitman L, Ovadya Y, Azazmeh N, et al
    Senolytic elimination of Cox2-expressing senescent cells inhibits the growth of premalignant pancreatic lesions.
    Gut. 2021 Mar 1. pii: gutjnl-2020-321112. doi: 10.1136/gutjnl-2020-321112.
    PubMed     Abstract available


    February 2021
  22. TACELLI M, Zaccari P, Capurso G, Arcidiacono PG, et al
    Artificial intelligence in EUS for autoimmune pancreatitis: bias and real life.
    Gut. 2021 Feb 22. pii: gutjnl-2021-324338. doi: 10.1136/gutjnl-2021-324338.
    PubMed    


  23. SUN X, He X, Zhang Y, Hosaka K, et al
    Inflammatory cell-derived CXCL3 promotes pancreatic cancer metastasis through a novel myofibroblast-hijacked cancer escape mechanism.
    Gut. 2021 Feb 10. pii: gutjnl-2020-322744. doi: 10.1136/gutjnl-2020-322744.
    PubMed     Abstract available


  24. PANDANABOYANA S, Moir J, Leeds JS, Oppong K, et al
    SARS-CoV-2 infection in acute pancreatitis increases disease severity and 30-day mortality: COVID PAN collaborative study.
    Gut. 2021 Feb 5. pii: gutjnl-2020-323364. doi: 10.1136/gutjnl-2020-323364.
    PubMed     Abstract available


  25. ADAM MG, Beyer G, Christiansen N, Kamlage B, et al
    Identification and validation of a multivariable prediction model based on blood plasma and serum metabolomics for the distinction of chronic pancreatitis subjects from non-pancreas disease control subjects.
    Gut. 2021 Feb 4. pii: gutjnl-2020-320723. doi: 10.1136/gutjnl-2020-320723.
    PubMed     Abstract available


    January 2021
  26. LUCHINI C, Grant RC, Scarpa A, Gallinger S, et al
    Microsatellite instability/mismatch repair deficiency in pancreatic cancers: the same or different?
    Gut. 2021 Jan 19. pii: gutjnl-2020-323805. doi: 10.1136/gutjnl-2020-323805.
    PubMed    


    November 2020
  27. RANA SS, Gupta R
    Walled of necrosis, disconnected pancreatic duct and metal stents: the debate continues!
    Gut. 2020 Nov 9. pii: gutjnl-2020-323190. doi: 10.1136/gutjnl-2020-323190.
    PubMed    


  28. FROST F, Kacprowski T, Ruhlemann M, Pietzner M, et al
    Long-term instability of the intestinal microbiome is associated with metabolic liver disease, low microbiota diversity, diabetes mellitus and impaired exocrine pancreatic function.
    Gut. 2020 Nov 9. pii: gutjnl-2020-322753. doi: 10.1136/gutjnl-2020-322753.
    PubMed     Abstract available


  29. KEMPENEERS MA, Issa Y, Verdonk RC, Bruno M, et al
    Pain patterns in chronic pancreatitis: a nationwide longitudinal cohort study.
    Gut. 2020 Nov 6. pii: gutjnl-2020-322117. doi: 10.1136/gutjnl-2020-322117.
    PubMed     Abstract available


    October 2020
  30. SANO M, Takahashi R, Ijichi H, Ishigaki K, et al
    Blocking VCAM-1 inhibits pancreatic tumour progression and cancer-associated thrombosis/thromboembolism.
    Gut. 2020 Oct 21. pii: gutjnl-2020-320608. doi: 10.1136/gutjnl-2020-320608.
    PubMed     Abstract available


  31. MARYA NB, Powers PD, Chari ST, Gleeson FC, et al
    Utilisation of artificial intelligence for the development of an EUS-convolutional neural network model trained to enhance the diagnosis of autoimmune pancreatitis.
    Gut. 2020 Oct 7. pii: gutjnl-2020-322821. doi: 10.1136/gutjnl-2020-322821.
    PubMed     Abstract available



  32. Correction: Loss of Setd2 promotes Kras-induced acinar-to-ductal metaplasia and epithelia-mesenchymal transition during pancreatic carcinogenesis.
    Gut. 2020;69:e6.
    PubMed    


  33. DIAFERIA GR, Natoli G
    Transcription factors as drivers of distinct pancreatic ductal adenocarcinoma (PDAC) programmes: a role for HNF4A.
    Gut. 2020 Oct 1. pii: gutjnl-2020-322814. doi: 10.1136/gutjnl-2020-322814.
    PubMed    


    September 2020
  34. WEISS FU, Laemmerhirt F, Lerch MM
    Next generation sequencing pitfalls in diagnosing trypsinogen (PRSS1) mutations in chronic pancreatitis.
    Gut. 2020 Sep 28. pii: gutjnl-2020-322864. doi: 10.1136/gutjnl-2020-322864.
    PubMed    


  35. BARRETO SG, Habtezion A, Gukovskaya A, Lugea A, et al
    Critical thresholds: key to unlocking the door to the prevention and specific treatments for acute pancreatitis.
    Gut. 2020 Sep 24. pii: gutjnl-2020-322163. doi: 10.1136/gutjnl-2020-322163.
    PubMed     Abstract available


  36. GRANT RC, Denroche R, Jang GH, Nowak KM, et al
    Clinical and genomic characterisation of mismatch repair deficient pancreatic adenocarcinoma.
    Gut. 2020 Sep 15. pii: gutjnl-2020-320730. doi: 10.1136/gutjnl-2020-320730.
    PubMed     Abstract available


  37. YOUNG K, Lawlor RT, Ragulan C, Patil Y, et al
    Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours.
    Gut. 2020 Sep 3. pii: gutjnl-2020-321016. doi: 10.1136/gutjnl-2020-321016.
    PubMed     Abstract available


  38. GOUT J, Perkhofer L, Morawe M, Arnold F, et al
    Synergistic targeting and resistance to PARP inhibition in DNA damage repair-deficient pancreatic cancer.
    Gut. 2020 Sep 1. pii: gutjnl-2019-319970. doi: 10.1136/gutjnl-2019-319970.
    PubMed     Abstract available


  39. VAN DEN BERG FF, van Dalen D, Hyoju SK, van Santvoort HC, et al
    Western-type diet influences mortality from necrotising pancreatitis and demonstrates a central role for butyrate.
    Gut. 2020 Sep 1. pii: gutjnl-2019-320430. doi: 10.1136/gutjnl-2019-320430.
    PubMed     Abstract available


    August 2020
  40. PERKHOFER L, Gout J, Roger E, Kude de Almeida F, et al
    DNA damage repair as a target in pancreatic cancer: state-of-the-art and future perspectives.
    Gut. 2020 Aug 27. pii: gutjnl-2019-319984. doi: 10.1136/gutjnl-2019-319984.
    PubMed     Abstract available


  41. CAMOLOTTO SA, Belova VK, Torre-Healy L, Vahrenkamp JM, et al
    Reciprocal regulation of pancreatic ductal adenocarcinoma growth and molecular subtype by HNF4alpha and SIX1/4.
    Gut. 2020 Aug 21. pii: gutjnl-2020-321316. doi: 10.1136/gutjnl-2020-321316.
    PubMed     Abstract available


  42. BASHA J, Lakhtakia S, Nabi Z, Pal P, et al
    Impact of disconnected pancreatic duct on recurrence of fluid collections and new-onset diabetes: do we finally have an answer?
    Gut. 2020 Aug 18. pii: gutjnl-2020-321773. doi: 10.1136/gutjnl-2020-321773.
    PubMed    


  43. MASI AC, Oppong YEA, Haugk B, Lamb CA, et al
    Endoscopic ultrasound (EUS)-guided fine needle biopsy (FNB) formalin fixed paraffin-embedded (FFPE) pancreatic tissue samples are a potential resource for microbiota analysis.
    Gut. 2020 Aug 18. pii: gutjnl-2020-322457. doi: 10.1136/gutjnl-2020-322457.
    PubMed    


  44. HUANG J, Chen P, Liu K, Liu J, et al
    CDK1/2/5 inhibition overcomes IFNG-mediated adaptive immune resistance in pancreatic cancer.
    Gut. 2020 Aug 14. pii: gutjnl-2019-320441. doi: 10.1136/gutjnl-2019-320441.
    PubMed     Abstract available



  45. Correction: STING signalling protects against chronic pancreatitis by modulating Th17 response.
    Gut. 2020;69:e5.
    PubMed    


    July 2020
  46. AGHDASSI A, Tran QT, Bulla T, Bulow R, et al
    Focal pancreatic lesions in autoimmune pancreatitis and weight loss.
    Gut. 2020 Jul 22. pii: gutjnl-2020-321987. doi: 10.1136/gutjnl-2020-321987.
    PubMed    


    June 2020
  47. LESINSKI GB
    Braking the cell's cycle and invigorating T-cell immunity against pancreatic cancer.
    Gut. 2020 Jun 22. pii: gutjnl-2020-321497. doi: 10.1136/gutjnl-2020-321497.
    PubMed    


  48. GUBATAN J, Levitte S, Patel A, Balabanis T, et al
    Prevalence, risk factors and clinical outcomes of COVID-19 in patients with a history of pancreatitis in Northern California.
    Gut. 2020 Jun 3. pii: gutjnl-2020-321772. doi: 10.1136/gutjnl-2020-321772.
    PubMed    



  49. Correction: Management of patients with increased risk for familial pancreatic cancer: updated recommendations for the international cancer of the pancreas screening (CAPS) Consortium.
    Gut. 2020;69:e3.
    PubMed    


    May 2020
  50. KNUDSEN ES, Kumarasamy V, Chung S, Ruiz A, et al
    Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer.
    Gut. 2020 May 18. pii: gutjnl-2020-321000. doi: 10.1136/gutjnl-2020-321000.
    PubMed     Abstract available


  51. MOLINA-MONTES E, Coscia C, Gomez-Rubio P, Fernandez A, et al
    Deciphering the complex interplay between pancreatic cancer, diabetes mellitus subtypes and obesity/BMI through causal inference and mediation analyses.
    Gut. 2020 May 14. pii: gutjnl-2019-319990. doi: 10.1136/gutjnl-2019-319990.
    PubMed     Abstract available


  52. TAKAHASHI R, Macchini M, Sunagawa M, Jiang Z, et al
    Interleukin-1beta-induced pancreatitis promotes pancreatic ductal adenocarcinoma via B lymphocyte-mediated immune suppression.
    Gut. 2020 May 10. pii: gutjnl-2019-319912. doi: 10.1136/gutjnl-2019-319912.
    PubMed     Abstract available


    April 2020
  53. LUCHINI C, Brosens LAA, Wood LD, Chatterjee D, et al
    Comprehensive characterisation of pancreatic ductal adenocarcinoma with microsatellite instability: histology, molecular pathology and clinical implications.
    Gut. 2020 Apr 29. pii: gutjnl-2020-320726. doi: 10.1136/gutjnl-2020-320726.
    PubMed     Abstract available


  54. TIAN J, Zhu Y, Rao M, Cai Y, et al
    N(6)-methyladenosine mRNA methylation of PIK3CB regulates AKT signalling to promote PTEN-deficient pancreatic cancer progression.
    Gut. 2020 Apr 20. pii: gutjnl-2019-320179. doi: 10.1136/gutjnl-2019-320179.
    PubMed     Abstract available


  55. DE-MADARIA E, Sanchez-Marin C, Carrillo I, Vege SS, et al
    Design and validation of a patient-reported outcome measure scale in acute pancreatitis: the PAN-PROMISE study.
    Gut. 2020 Apr 3. pii: gutjnl-2020-320729. doi: 10.1136/gutjnl-2020-320729.
    PubMed     Abstract available


  56. HU Q, Wu J, Ren Y, Wu X, et al
    Degree of STING activation is associated with disease outcomes.
    Gut. 2020;69:792-794.
    PubMed    


    February 2020
  57. BANG JY, Hawes RH, Varadarajulu S
    Lumen-apposing metal stent placement for drainage of pancreatic fluid collections: predictors of adverse events.
    Gut. 2020 Feb 17. pii: gutjnl-2019-320539. doi: 10.1136/gutjnl-2019-320539.
    PubMed    


  58. STOLZENBERG-SOLOMON R, Derkach A, Moore S, Weinstein SJ, et al
    Associations between metabolites and pancreatic cancer risk in a large prospective epidemiological study.
    Gut. 2020 Feb 14. pii: gutjnl-2019-319811. doi: 10.1136/gutjnl-2019-319811.
    PubMed     Abstract available


    January 2020
  59. BIEDERSTADT A, Hassan Z, Schneeweis C, Schick M, et al
    SUMO pathway inhibition targets an aggressive pancreatic cancer subtype.
    Gut. 2020 Jan 30. pii: gutjnl-2018-317856. doi: 10.1136/gutjnl-2018-317856.
    PubMed     Abstract available


  60. WAN J, Haddock A, Edenfield B, Ji B, et al
    Transgenic expression of human PRSS2 exacerbates pancreatitis in mice.
    Gut. 2020 Jan 23. pii: gutjnl-2019-320399. doi: 10.1136/gutjnl-2019-320399.
    PubMed    


    December 2019
  61. FRAMPTON AE, Giovannetti E
    Diagnosing pancreatic ductal adenocarcinoma using plasma extracellular vesicle RNA profiles.
    Gut. 2019 Dec 4. pii: gutjnl-2019-319896. doi: 10.1136/gutjnl-2019-319896.
    PubMed    


    October 2019
  62. GOGGINS M, Overbeek KA, Brand R, Syngal S, et al
    Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium.
    Gut. 2019 Oct 31. pii: gutjnl-2019-319352. doi: 10.1136/gutjnl-2019-319352.
    PubMed     Abstract available


  63. LIANG C, Shi S, Qin Y, Meng Q, et al
    Localisation of PGK1 determines metabolic phenotype to balance metastasis and proliferation in patients with SMAD4-negative pancreatic cancer.
    Gut. 2019 Oct 14. pii: gutjnl-2018-317163. doi: 10.1136/gutjnl-2018-317163.
    PubMed     Abstract available


  64. TOLOSA EJ, Fernandez-Zapico ME
    Targeting tumour microenvironment, a FAKtual challenge in pancreatic cancer.
    Gut. 2019 Oct 3. pii: gutjnl-2019-318962. doi: 10.1136/gutjnl-2019-318962.
    PubMed    


    September 2019
  65. YU S, Li Y, Liao Z, Wang Z, et al
    Plasma extracellular vesicle long RNA profiling identifies a diagnostic signature for the detection of pancreatic ductal adenocarcinoma.
    Gut. 2019 Sep 27. pii: gutjnl-2019-318860. doi: 10.1136/gutjnl-2019-318860.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Pancreatitis is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: